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Macrophages tightly control the production and clearance of red blood cells (RBC).
During steady state hematopoiesis, approximately 1010 RBC are produced per hour within
erythroblastic islands in humans. In these erythroblastic islands, resident bone marrow
macrophages provide erythroblasts with interactions that are essential for erythroid
development. New evidence suggests that not only under homeostasis but also under
stress conditions, macrophages play an important role in promoting erythropoiesis. Once
RBC have matured, these cells remain in circulation for about 120 days. At the end of their
life span, RBC are cleared by macrophages residing in the spleen and the liver. Current
theories about the removal of senescent RBC and the essential role of macrophages will
be discussed as well as the role of macrophages in facilitating the removal of damaged
cellular content from the RBC. In this review we will provide an overview on the role of
macrophages in the regulation of RBC production, maintenance and clearance. In addition,
we will discuss the interactions between these two cell types during transfer of immune
complexes and pathogens from RBC to macrophages.
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FROM ERYTHROBLASTIC ISLANDS TO CLEARANCE
During their development and mature life, red blood cells (RBC)
interact numerous times with macrophages, first during their
development in the bone marrow, later in the blood stream with
macrophages in the liver and spleen. All of these interactions are
essential for efficient production under different conditions, to
maintain RBC homeostasis or to ensure the correct removal of
aged or damaged RBC. In this review, an overview of the dif-
ferent processes in which RBC-macrophage interactions play an
important role is given.
THE ERYTHROBLASTIC ISLAND; A LYING-INROOM FOR
EFFECTIVE ERYTHROPOIESIS
Adult erythropoiesis is a tightly regulated process which occurs
in the bone marrow. It consists of several developmental
stages: hematopoietic stem cell, burst- forming unit- erythroid
(BFU-E), colony- forming unit- erythroid (CFU-E), proery-
throblast, basophilic erythroblast, polychromatic erythroblast,
orthochromatic erythroblast, reticulocyte and ultimately to
mature RBC (Manwani and Bieker, 2008; An and Mohandas,
2011). Erythrocyte production is regulated by a negative feedback
loop where oxygen levels determine plasma levels of erythropoi-
etin (Epo). Even though there are a number of growth factors
known to participate in the regulation of erythropoiesis, Epo
has been identified as the master regulator of RBC production
(Ji et al., 2011). Epo drives RBC precursor proliferation and
differentiation and can prevent erythroblast apoptosis (Koury
and Bondurant, 1990). Furthermore, terminal erythropoiesis has
been reported to take place in a specialized microenvironment
called the erythroblastic island. Erythroblastic islands were first
described in 1958 by Besis who characterized them by analysing
transmission electron micrographs of bone marrow sections.
He showed a structure containing a macrophage surrounded
by developing erythroblasts (Bessis, 1958) and concluded that
macrophages actively participate in erythroid development by
providing iron for heme synthesis and by phagocytosing expelled
nuclei during final erythroid differentiation (Bessis and Breton-
Gorius, 1962). Moreover, in 1972 a functional role of erythroblas-
tic islands was demonstrated by comparing erythroblastic islands
of normal rats and hypertransfused rats and showing that hyper-
transfused rats exhibit a significant reduction in erythroblast
islands numbers by using 3D electron microscopy (Mohandas
and Prenant, 1978). This finding suggests that suppression of
erythropoiesis by means of RBC transfusion would result in
diminished erythroid island formation, linking erythropoiesis
rate to the number of erythroblastic islands. Erythroblastic islands
have been described during primitive erythropoiesis as well. Even
though erythroblasts in the yolk sac do not require a special-
ized microenvironment for development, they attach closely to
structures highly similar to erythroblastic islands (McGrath et al.,
2008). Moreover, erythroblastic islands have been reported in
other sites for definitive erythropoiesis such as fetal liver and
splenic red pulp (Manwani and Bieker, 2008).
Structurally, unlike megakaryocytes which are situated close
to bone marrow sinusoids, to ensure fast egress into circulation
when platelets are needed, erythroblastic islands are unevenly dis-
tributed inside the marrow, with islands adjacent or distant from
the sinusoids. However, it should be noted that in vivo stud-
ies on erythroblastic islands in humans is virtually impossible,
therefore a lot of experiments have been performed using animal
models. In a study dissecting rat bone marrow, quantitative light
and electron microscopy analysis shows that nonadjacent islands
accommodate more pro-erythroblasts, while on the other hand
islands situated next to sinusoids contain more differentiated
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erythroblasts (Yokoyama et al., 2003). This interesting observa-
tion proposes that erythroblastic islands are capable of migrating
towards bone marrow sinusoids as erythroid precursors mature.
It is possible that interactions between erythroblast and central
macrophage trigger a cascade leading to the release ofmacrophage
proteases, which would aid extracellular matrix remodeling, and
hence island progression to the sinusoid. Moreover, erythroblasts
can potentially attach and detach from one central macrophage
to another, thus facilitating their movement further to sinusoids.
Nevertheless, the interaction between macrophage and differen-
tiating erythroid precursors appear to be essential throughout
erythropoiesis.
ROLE OF MACROPHAGES IN ERYTHROPOIESIS
Despite the fact that erythroblastic islands were described a
few decades ago, understanding of the interactions between
macrophages and erythroblasts during erythropoiesis is incom-
plete. To begin with, the specific erythroblast island cellular com-
position can vary depending on the species. Evidence obtained
from tissue sections of rat femur shows roughly 10 erythroblasts
per island (Yokoyama et al., 2002), while islands collected from
human bonemarrow can contain 5–30 erythroblasts surrounding
a central macrophage (Lee et al., 1988).
As mentioned earlier, macrophages were proposed to promote
erythropoiesis by directly transferring iron to erythroid progen-
itors (Bessis and Breton-Gorius, 1962). It should be noted that
splenic red pulp macrophages are mainly responsible for iron
return to bone marrow from recycling of senescent and dam-
aged erythrocytes, after catabolism of hemoglobin molecules.
Recently it was demonstrated in an erythroblastic island culture
that ferritin produced by macrophages is released by exocytosis
and engulfed by erythroblasts via endocytosis (Figure 1). Once
inside the erythroblast, iron is released from ferritin upon acidifi-
cation and proteolysis, thus being subsequently available for heme
FIGURE 1 | Role of macrophages in erythropoiesis. In the erythroid
niche, macrophages not only provide iron for developing erythroblasts but
also phagocytose expelled nuclei. Furthermore, the macrophage protein
DNaseII is important for breakdown of nuclei that are expelled by
erythroblasts.
production in the erythroid precursor cell (Dautry-Varsat et al.,
1983; Leimberg et al., 2008; Hentze et al., 2010; Li et al., 2010b).
There are several examples in literature showing that
macrophages not only promote erythropoiesis by providing iron,
but also by directly stimulating proliferation and survival of ery-
throblasts. When erythroblasts are cultured in vitro, the erythroid
precursors attached to macrophages are subjected to enhanced
proliferation compared to non-attached erythroblasts proposing
that macrophages may augment the response to Epo upon direct
interaction with erythroblasts (Rhodes et al., 2008).
It has been demonstrated that abnormal macrophage differen-
tiation can have a direct effect on erythroblastic island function.
For instance, when retinoblastoma tumor suppressor (Rb) pro-
tein is knocked out in a mouse model, fetuses die in utero due to
anemia (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992). Rb
is a nuclear factor that regulates cell cycle transition from G1 to
S phase and is critical for macrophage differentiation (Iavarone
et al., 2004).
Cytoskeletal-associated protein palladin has also been impli-
cated in macrophage function. It is a protein that localizes in focal
adhesions of stress fibers together with α- actinin, thus promot-
ing cytoskeletal dynamic rearrangements and adherence to the
extracellular matrix. Knocking out palladin in a mouse model
is embryonic lethal due to anemia caused by erythroblast cell
death and aberrant terminal erythroid differentiation. Fetal liver
erythroblastic island integrity is compromised and in vitro ery-
throblastic island formation is perturbed in palladin−/−mice due
to an intrinsic macrophage defect (Liu et al., 2007).
In addition, the macrophage transcription factor c-Maf has
been identified as a critical component in definitive erythropoiesis
in fetal liver. Deletion of c-Maf leads to severe erythropenia
in utero and significant reduction in fetal liver erythroblastic
island formation compared to wild type. The observed defective
erythropoiesis seems to be due to an abnormal erythroid niche
and not to a cell autonomous effect (Kusakabe et al., 2011). These
examples clearly show that macrophages are crucial participants
in erythroid development as targeted deletion of enzymes, pro-
teins and transcription factors responsible for macrophage pro-
liferation and survival ultimately results in perturbed erythroid
niche formation and defective erythropoiesis.
DIRECT INTERACTIONS BETWEEN ERYTHROBLASTS AND
MACROPHAGES WITHIN ERYTHROBLASTIC ISLANDS
Needless to say, the function and integrity of erythroblastic
islands is tightly related to the molecular interactions occur-
ring between erythroid precursors and the central macrophage.
Erythroblasts express a myriad of adhesion molecules throughout
their differentiation, which not only facilitate adhesion to extra-
cellular matrix proteins such as fibronectin and laminin, but also
attachment to the central macrophage. The first molecule identi-
fied on the surface of both central macrophages and erythroblasts
is Erythroblast macrophage protein (Emp), a protein that pro-
motes binding between the two cell types (Hanspal and Hanspal,
1994) (Figure 2). In erythroblastic island cultures absence of Emp
leads to aberrant erythropoiesis and increased levels of apopto-
sis (Hanspal et al., 1998), suggesting that the direct association
between the central macrophage and the erythroblasts is essential
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for erythroid maturation and prevention of cell death. In sup-
port of those findings are the in vivo experiments performed with
Emp deficient mice, which show that those animals die before
birth owing to severe anemia (Soni et al., 2006). Next, another
important molecular interaction found in erythroblastic islands
occurs between the α4β1 integrin (Very Late Antigen 4; VLA-4)
on erythroblasts and vascular cell adhesion molecule 1 (VCAM-
1) on central macrophages (Figure 2). The biological significance
of this receptor pair is underlined in experiments in which ery-
throid island formation is perturbed by antibodies against α4β1
integrin or VCAM-1 (Sadahira et al., 1995). Studies in mice
have shown that integrins have a pivotal role in stress erythro-
poiesis (Ulyanova et al., 2011). In addition, intercellular adhesion
molecule 4 (ICAM-4) expressed on erythroblasts and αV inte-
grin present on macrophages (Figure 2) have a vital function in
maintaining island integrity, since disrupting the binding between
the two molecules using synthetic peptides leads to a diminished
number of erythroblastic islands. In an in vivo model, utilizing
ICAM-4 deficient mice, reduced island formation is observed as
well (Lee et al., 2006). Moreover, a secreted form of ICAM-4 pos-
sibly regulates terminal erythropoiesis by competing with surface
ICAM-4 for αV integrin on central macrophages preventing the
interaction between erythroblasts and macrophage (Lee et al.,
2003).
CD163 is another macrophage receptor that interacts with
erythroblasts (Fabriek et al., 2007) (Figure 2). CD163 is well-
known to scavenge hemoglobin-haptoglobin complexes, thus
clearing free hemoglobin from circulation (Kristiansen et al.,
2001). CD163 contains an erythroblast adhesion motif as well,
which mediates binding of macrophages to erythroid precur-
sors facilitating erythroblast expansion and survival (Fabriek
FIGURE 2 | Direct interactions between the central macrophage and
developing erythroblasts. Macrophages express VCAM-1 and integrin αV
on their surface facilitating interaction with erythroblasts through integrin
α4β1 and ICAM-4, respectively. Moreover, both erythroid cells and
macrophages express Emp on their surface promoting their interactions in
the niche. Central macrophage and erythroblast can also interact via the
ligand-receptor pair EphB4 (expressed on the surface of erythroblasts) and
Ephrin-2, found on macrophages.
et al., 2007). Future studies are required to further characterize
the contribution of the direct interactions between erythrob-
lasts and macrophages on island structural integrity and on
signaling pathways during erythropoiesis. For instance, the spe-
cific receptor/ligand pairs on erythroblasts and macrophage that
are involved in cell-cycle regulation during erythropoiesis have
not yet been identified. Likely candidates are macrophage mem-
brane protein Ephrin-2 (HTK ligand) binding erythroid receptor
EphB4 (HTK) (Figure 2) (Inada et al., 1997; Suenobu et al.,
2002) and c-kit ligand interacting with c-kit on erythroblasts
(Muta et al., 1995). Bothmacrophage surfacemolecules have been
shown to augment erythroid proliferation.
SOLUBLE FACTORS IMPORTANT IN ERYTHROBLASTIC
ISLANDS
Interestingly, there is experimental evidence suggesting that
erythroblasts might modulate island integrity by secreting angio-
genic factors such as vascular endothelial growth factor A (VEGF-
A) and placental growth factor (PGF) (Tordjman et al., 2001)
(Figure 3). One can hypothesize that release of these molecules
can contribute to the reticulocytes’ egression into the vascula-
ture by regulating the stability of endothelial junctions. Moreover,
even though erythroblasts do not express receptors for VEGF-A
and PGF on their surface, central macrophages do, suggesting that
erythroblasts may secrete those factors as paracrine modulators of
macrophage proliferation and survival in the erythroid niche.
On the other hand, growth arrest-specific 6 (Gas-6) released
by erythroblasts has been proposed to modulate the erythroid
microenvironment during erythropoiesis. Gas-6 is a molecule
normally associated with proliferation and survival of non-
erythroid cells. However, erythroblasts can secrete Gas-6 in
response to Epo, thus positively regulating Epo signaling through
FIGURE 3 | Soluble factors important for erythropoiesis. Both central
macrophage and erythroblast secrete soluble factors during erythropiesis.
These include the negative regulators TNF-α, TGF-β, IL-6, IFN-γ released by
the central macrophage, and the positive regulators Gas-6, VEGF-A and PGF
released by erythroblasts. TRAIL is a negative regulator secreted by both
erythroid cells and macrophages.
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phosphoinositide 3 kinase (PI3K) and Akt activation (Angelillo-
Scherrer et al., 2008).
Furthermore, there are several soluble factors secreted by
macrophages within the erythroblastic island that negatively
regulate erythropoiesis. These include cytokines, chemokines
and interleukins including interleukin 6 (IL-6), transforming
growth factor-β (TGF-β), tumor necrosis factor-α (TNF-α),
and interferon-γ (INF-γ), all of which are associated with
chronic inflammation and tumor progression. For instance,
patients suffering from chronic inflammation have high levels
of inflammatory cytokines in the bone marrow which inhibit
erythropoiesis (Means, 2004). The mechanism by which TNF-
α released by macrophages suppresses erythropoiesis involves
caspase-mediated cleavage of GATA-1, a pivotal transcriptional
regulator of erythroid development. This leads to apoptosis (De
Maria et al., 1999) or delayed proliferation (Dai et al., 2003)
of the erythroid progenitors. During terminal differentiation
GATA-1 is normally protected from caspase cleavage by heat
shock protein 70 (Hsp-70) (Ribeil et al., 2007). Thus Hsp-
70 can regulate erythropoiesis by preventing the induction of
apoptosis which would negatively influence RBC production.
Furthermore, secreted TNF-α can trigger release of metallopro-
teases by macrophages in order to remodel extracellular matrix
in other tissues, however a similar event occurring in the con-
text of erythroblastic islands would have deleterious effects on the
microenvironment’s integrity.
Bonemarrowmacrophages isolated frommyelodysplastic syn-
drome (MDS) patients release higher levels of TNF-α compared
to macrophages from healthy donors (Flores-Figueroa et al.,
2002). Moreover, they present with an increased apoptotic index,
suggesting an abnormal macrophage function inside the ery-
throid niche in MDS.
Additionally, TGF-β released by macrophages is known to
block erythroblast proliferation and survival via a mechanism dif-
ferent than apoptosis, and at the same time enhances erythroid
differentiation (Zermati et al., 2000). TGF-β can activate Rho and
Rac GTPases, influencing cell cytoskeletal stability and organiza-
tion in various cell types (Maddala et al., 2003), including ery-
throblasts, which require stable cytoskeletal integrity for normal
development. Increased levels of the inflammatory cytokine IFN-
γ can lead to secretion of TNF-related apoptosis inducing ligand
(TRAIL), by both macrophages and erythroblasts (Zamai et al.,
2000). TRAIL blocks erythroid differentiation by a activating
the ERK/MAPK (extracellular signal-regulated kinase/mitogen-
activated protein kinase) pathway (Secchiero et al., 2004). All
soluble factors discussed above are depicted in Figure 3. Notably,
many studies on erythroblastic islands and erythroid prolifera-
tion and survival manage to establish the crucial link between
macrophage and erythroblast interactions and their effects on
erythroid niche development.
MACROPHAGES PHAGOCYTOSE NUCLEI EXPELLED
FROM ERYTHROBLASTS
During the final stage of terminal erythroid differentiation, the
erythroblast expels its nucleus as part of its maturation into
a reticulocyte. The macrophage has a critical role during this
process since it will phagocytose the expelled nucleus, aiding
erythropoiesis (Seki and Shirasawa, 1965; Skutelsky and Danon,
1972). Both the macrophage and the erythroblast/reticulocyte are
equipped with adhesion molecules promoting the retention of
the nucleus on the surface of the macrophage before phagocy-
tosis takes place. It has been shown that Emp (Soni et al., 2006)
and β1 integrin (Lee et al., 2004) predominantly distribute on the
nucleus after expulsion, thus maintaining the interaction between
the nucleus and the macrophage. Moreover, studies performed
with fetal liver erythroblasts demonstrate that expelled nuclei
expose phosphatidylserine (PS) on their surface for 10min after
expulsion (Yoshida et al., 2005) (Figure 1). This observation cor-
roborates with the finding that the time frame between nucleus
expulsion and phagocytosis is 10min (Allen and Testa, 1991),
which suggests that PS might be assisting in the adhesion of the
nucleus to the macrophage prior to phagocytosis. PS is a mem-
brane component normally situated on the inner leaflet of the
cell membrane. An ATP-dependent aminophospholipid translo-
case enzyme maintains the lipid asymmetry by keeping PS on
the inside of the plasma membrane. PS exposure on the cell sur-
face is considered an apoptotic signal targeting cells undergoing
cell death for clearance by phagocytes expressing PS receptors.
Moreover, PS externalization can be a direct effect of ATP deple-
tion in the cell. In addition, Yoshida and colleagues have demon-
strated that expelled nuclei expose PS and lack ATP (Yoshida
et al., 2005). Furthermore, the PS-binding protein lactadherin
(also known as MFGE8) which normally serves as a bridging
molecule between an apoptotic cell and a phagocyte (Hanayama
et al., 2002), has been shown to be crucial for phagocytosis of
extruded erythroblast nucleus as well. A mutated form of lactad-
herin, not being able to bind PS, inhibits phagocytosis of expelled
nuclei (Yoshida et al., 2005).
Another study that suggests an important role for
macrophages for the phagocytosis and degradation of expelled
nuclei during erythropoiesis made use of DNase II deficient
mice. DNase II is an enzyme necessary to degrade nuclear DNA
after phagocytosis and proves to be essential for erythropoiesis
(Kawane et al., 2001) (Figure 1). It was shown that fetal liver
macrophages from DNase II deficient mice are unable to degrade
the ingested nuclei and that DNase II-null mice die in utero due
to severe anemia.
MACROPHAGES IN ERYTHROPOIESIS: IN HEALTH
AND DISEASE
Despite the fact that our knowledge of macrophage-erythroblast
interactions in erythroblastic islands and their role in erythroid
development is expanding, it is important to realize that many of
the experiments have been conducted in vitro. In a recent paper
Chow and colleagues elegantly show that CD169+ macrophages
promote erythropoiesis in steady state and under stress in vivo
(Chow et al., 2013). CD169 was first described to be a marker of
central macrophages in the erythroblastic island more than two
decades ago (Crocker et al., 1990). In the study by Chow et al.
depletion of CD169+ macrophages leads to a decreased num-
ber of erythroblasts in the bone marrow and mild iron-deficiency
anemia. Furthermore, CD169+ macrophages appear to be essen-
tial for recovery from hemolytic anemia, acute blood loss and
myeloablation. On the other hand,macrophage depletion can res-
cue the phenotype of polycythemia vera in a JAK2V617F- driven
mouse model. These findings suggest that macrophages are not
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only a critical component during erythroid maturation in steady
state, but also during stress and disease.
To support the speculation that macrophages might also have
a function in erythropoiesis in the context of disease and to
further characterize their importance in erythropoiesis in vivo,
Ramos and colleagues show that macrophages regulate erythroid
development in polycythemia vera, β-thalassemia and anemia
(Ramos et al., 2013). Chemical depletion of macrophages by
clodronate liposome administration prevents mice from recov-
ering from induced anemia, suggesting an essential function
of macrophages in promoting stress erythropoiesis in vivo.
Conversely, macrophage depletion not only improves the pheno-
type of polycythemia vera and reverses the pathological aspects of
the disease, but also alleviates anemia caused by β-thalassemia.
These results propose an important dual role of macrophages
in physiological and pathological erythropoiesis in vivo. Both
studies suggest that macrophages exert two seemingly contradic-
tory actions on erythropoiesis. On one hand, macrophages are
indispensable for stress erythropoiesis in vivo. In their absence
erythroid production in the bone marrow and spleen in response
to bleeding is impaired. However, macrophages can also be dele-
terious in the context of polycythemia vera and β-thalassemia,
since depletion of macrophages leads to a decreased disease
pathology. Moreover, ex vivo cultured human macrophages from
polycythemia vera patients promote proliferation of human ery-
throblasts and diminish differentiation. This suggests a function
for macrophages in disease progression since polycythemia vera
is characterized by an overactive erythron and excessive erythro-
poiesis (Ramos et al., 2013). These findings might pave the way
to future therapies implementing macrophage depletion in the
treatment of erythroid disorders like polycythemia vera and β-
thalassemia. These and other studies demonstrate the importance
of erythroblastic islands and more specifically, the interaction
between macrophage and erythroblasts for RBC maturation in
physiological and pathological conditions. Future experiments
are necessary to examine in more detail the involvement of
macrophages in red blood cell production in steady state and dis-
ease. Even though, animal models are necessary to illustrate the
in vivo situation, one should take these studies into considera-
tion with caution. It should be noted that erythroid development
within erythroblastic islands differs between mice and men.
INTERACTION OF RBC AND MACROPHAGES IN THE
BLOODSTREAM
After they are produced in the bone marrow, RBC remain in
circulation for roughly 120 days. Throughout their life span
RBC pass the liver and the spleen numerous times where they
encounter resident macrophages (Crosby, 1959). The interac-
tions between macrophages and RBC taking place in liver and
spleen are important for RBC homeostasis and ultimately for the
removal and degradation of aged RBC at the end of their life
span (Mebius and Kraal, 2005). In addition, macrophages take up
immune complexes and pathogens bound to complement recep-
tor 1 (CR1) on the RBC and can clear intracellular pathogens such
as Plasmodium from the RBC, leaving the RBC intact and allow-
ing the return of the RBC into circulation (Wilson et al., 1987).
The different molecular interactions that are important for these
different processes are discussed below.
THE REMOVAL OF INTRACELLULAR INCLUSIONS BY
MACROPHAGES OF THE SPLEEN
The macrophages of the spleen have a remarkable function that
enables them to remove unwanted damage from the RBC mem-
brane, leaving the RBC intact (Crosby, 1957; Schnitzer et al.,
1972). Removal of these intracellular inclusions seems to occur
within the open circulation where the RBC are also checked
for their loss of deformability to check for age. To achieve this,
RBC must pass through the endothelial slits of the sinus to
reenter the blood circulation. During this course, cells that are
non-deformable will be removed from the circulation by resi-
dential macrophages. In the mean-time all inclusion bodies are
also being removed. In splenectomized patients or in patients
with a non-functional spleen, phagocytosis of the inclusion bod-
ies fails and results in a retention of a variety of intracellular
inclusions within the RBC, such as Howell-jolly bodies (inclu-
sions of nuclear chromatin remnants) (Wilkins and Wright,
2000), Heinz bodies (inclusions of denatured hemoglobin caused
by oxidative damage) (Wilkins and Wright, 2000) siderocytes
(RBC containing granules of iron that are not part of the cell’s
hemoglobin) (Wilkins and Wright, 2000) and Pappenheimer
bodies inclusion bodies formed by phagosomes that have been
engulfing excessive amounts of iron (Wilkins and Wright,
2000).
Back in 1957 Crosby already showed that when siderocytes,
tagged with radioactive chromium, were injected into a healthy
patient with a functional spleen, there was a decline in siderocyte
count without the loss of chromium labeled RBC. When the
same amount of siderocytes was injected into a splenectomized
patient, the amount of siderocytes remained unaltered during
the 24-h period of observation. This study hereby demonstrated
that passage through the spleen can lead to clearance of dam-
age that is accumulating in the circulating RBC. Furthermore,
it revealed that processing of damage from RBC can take place
while leaving the RBC intact. Thus, it seems that the spleen and
the residential macrophages are highly important in maintain-
ing RBC “healthy.” RBC are of course unable to synthesize new
proteins, and although equipped with enzyme systems to coun-
teract the potential toxic effects of the oxygen they transport,
they will sustain oxidative damage throughout their life resulting
in the formation of Heinz bodies (Harley, 1965). The molecu-
lar mechanism that underlies the removal of inclusion bodies is
largely unknown. In Willekens et al. (2003) presented an analogy
to the removal of Heinz bodies when discussing RBC that lose
hemoglobin through vesiculation. Via the process of RBC vesicu-
lation the RBC loses aggregated hemoglobin, which is important
to maintain the homeostasis of RBC, increases in density and
becomes smaller (Piomelli and Seaman, 1993). It was suggested
that this process is also facilitated by the macrophages of the
spleen, in which older cells vesiculate more than younger ones.
Clearly, macrophages play a pivotal role in the clearance of dam-
aged content from circulating RBC (Crosby, 1957;Willekens et al.,
2003) and vesiculation is an interesting and plausible mechanism
to explain the efficient removal of damaged content while leaving
the RBC intact (Wilson et al., 1987). The molecular mechanism
by which macrophages in the spleen would be facilitating RBC
vesiculation is still unknown. Ultrastructural studies of spleens
from monkeys infected with Plasmodium knowlesi suggest that
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the spleen also removes malaria parasites from red cells, in which
once again phagocytes play the main role (Schnitzer et al., 1972).
In addition, interesting work by Buffet and colleagues has pointed
out that the removal of malaria parasites from RBC occurs in the
red pulp of the spleen, using perfused human spleens to proof
this point (Buffet et al., 2006). Several studies suggest that due
to this function the spleen plays a major protective role in naïve
patients (Bachmann et al., 2009; Munasinghe et al., 2009). They
all showed that disease severity, parasitemia and mortality were
higher in splenectomized patients. This supports the hypothesis
that without a functional spleen, there will be no splenic reten-
tion which could explain why the outcome in splenectomized
patients compared to patients who have a functional spleen
is worse.
RBC REMOVAL BY MACROPHAGES
Residential macrophages of the spleen are able to scrutinize pass-
ing RBC and remove those from the circulation that are at the end
of their lifespan or have sustained damage beyond repair (Mebius
and Kraal, 2005). For example: deformed RBC that have been pro-
duced by mistake by the bone marrow or RBC that are affected by
hereditary spherocytosis will be taken up by spleen macrophages
in the red pulp (Crary and Buchanan, 2009).
At present there is no consensus as to how red pulp
macrophages determine which RBC need to be cleared and which
can be repaired and/or maintained. It is difficult to identify RBC
that are destined to be cleared in vivo due to the fact that RBC
that are carrying a removal signal will most likely be phagocytosed
and hence will no longer be available for analysis. In addition, the
proportion of RBC that is daily cleared is a mere 0.8% per day,
thus leaving only a very small number of RBC that will carry the
removal signals at any given moment a blood sample is taken.
Therefore, most of the theories on possible removal signals for
RBC phagocytosis are based on in vitrowork or on data generated
in animal models.
The RBC aging phenotype, according to our current knowl-
edge, is associated with a decline in metabolic activity and
progressive membrane remodeling, due to for example oxida-
tive stress and vesiculation. Concomitantly, the RBC becomes
smaller and more dense (Piomelli and Seaman, 1993). Despite
these cumulative events, the removal signals do not seem to grad-
ually accumulate on RBC. On the opposite, they appear as a
snap, rapid and non-linear cascade of events at the terminal stage
of the aging process, probably shortly before RBC are removed
by macrophages (Franco, 2009). Taking into account that RBC
are unable to synthesize new proteins, all “removal” markers
must derive from modifications in pre-existing molecules or
to the acquisition of plasma-derived opsonins directed against
these modifications. Although RBC do not undergo classi-
cal apoptosis since they do not contain a nucleus, mitochon-
dria or other cellular organelles, the process they undergo has
already been termed “eryptosis” since it exhibits many simi-
larities with programmed cell death (Lang et al., 2005). For
instance, it is highly likely that phagocytosis of senescent RBC
will be non-inflammatory. Thus far, there have been several
mechanisms postulated for the clearance of senescent RBC by
macrophages.
BAND 3-BASED CLEARANCE MECHANISM
Band 3, a transmembrane protein that constitutes 25% of the total
amount of RBCmembrane proteins, has been postulated to be the
major target of natural occurring antibodies (NAbs) of the IgG
isotype and might be a central step in clearance of senescent and
damaged RBC that is mediated bymacrophages (Lutz, 2004; Arese
et al., 2005; Kay, 2005) Band 3 has two different domains: the
membrane spanning domain that catalyses anion exchange and
is recognized by Nabs (after clustering) (Figure 4), and a cyto-
plasmic domain that regulates the structure and function of the
RBC by binding different proteins (Zhang et al., 2000; Pantaleo
et al., 2008). There is still debate about the mechanism that leads
to formation of the epitope on band 3 that results in binding
of NAbs. It is thought that oxidative damage to hemoglobin,
occurring throughout its lifecycle, and the following formation
of hemichromes which bind to band 3, can in time lead to band 3
clustering (Pantaleo et al., 2008; Arashiki et al., 2013). NAbs show
an enhanced affinity to band 3 clusters (Low, 1986; Mannu et al.,
1995; Hornig and Lutz, 2000). Another hypothesis is that pro-
teolytic degradation of band 3 is essential to shape the band 3
epitopes recognized by NAbs (Kay, 2004).
However, NAbs are not efficient opsonins, due to their low
affinity and low circulation numbers. It has been hypothesized
that phagocytosis of RBC can be enhanced by the activation of
the classical pathway of the complement system after NAb bind-
ing. These NAbs preferentially generate C3b2–IgG complexes in
the presence of active complement (Lutz et al., 1993). Once the
FIGURE 4 | Interactions between mature RBC and spleen
macrophages. RBC can interact with spleen macrophages via direct
receptor ligand pairing or via bridging molecules. Ageing RBC express PS
on their surface which can directly bind to Stabilin-2 or Tim-4 on the
macrophage or via opsonins such as Gas-6, lactadherin or
thrombospondin-1. RBC express CR1 on their surface which can bind C3b
osponized particles and further facilitate interaction with spleen
macrophages via CR1 and CR3. Nabs can bind Band-3 on the surface of
RBC targeting the cell for clearance via Fc receptors on the spleen
macrophages. Moreover, RBC express CD47 which binds SIRPα on
macrophages.
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classical pathway is activated a significantly lower amount of NAbs
is needed for induction of phagocytosis (Lutz et al., 1990). This is
because once opsonized with C3b, C3b will form complexes with
NAbs that are more resistant to inactivation factors such as: H and
I. Red pulp macrophages express CR1 (C3b-receptor, CD35) and
CR3 (iC3b-receptor, CD11b/CD18) (Burger and van Bruggen,
unpublished) that would enable them to recognize and phago-
cytose complement opsonized RBC (Figure 4). However, phago-
cytosis through either of these receptors usually results in the
secretion of pro-inflammatory cytokines, although the opposite
effects, thus an inhibition of the secretion of pro-inflammatory
cytokines has also been shown (Morelli et al., 2003). The effect
of complement receptor-mediated phagocytosis on cytokine
secretion in macrophages of the spleen is currently under
investigation.
REMOVAL OF AGED RBC BY PHOSPHATIDYLSERINE
RECOGNIZING RECEPTORS ON MACROPHAGES
In healthy cells phosphatidylserine (PS), is normally found on the
inner leaflet of the RBC membrane. However, when apoptosis is
induced a large increase is seen in the amounts of PS exposed
at the cell surface. This increase in PS expression is proposed to
be an “eat me” signal for phagocyte recognition of an apoptotic
cell, resulting in a non-inflammatory clearance of the dying cell
(Fernandez-Boyanapalli et al., 2009).
In an in vivo experiment, an increase in PS exposure is seen
with RBC age, correlated to the RBC clearance from the circu-
lation (Boas et al., 1998). For a long time it has been proposed
that apoptotic cells that express PS can be cleared from circu-
lation via macrophages by recognizing them through specific
PS-receptors (Li et al., 2003). Yet recently, various receptors have
been identified that can mediate binding and phagocytosis of
apoptotic cells by the recognition of PS on these cells such as
Tim1, Tim4 and Stabilin-2 (Kobayashi et al., 2007; Park et al.,
2008). In addition, there are several bridging molecules such
as the plasma proteins: lactadherin, Gas-6 and protein S, that
have been described to bind to PS and direct PS to receptors on
phagocytes, αvβ3/5 integrins and receptors of the TAM receptor
family and mediate clearance of PS-positive cells (Raymond et al.,
2009). Of these receptors, at least Axl, Tim4 and Stabilin-2 are
expressed in red pulp macrophages (Burger and van Bruggen,
unpublished) (Figure 4). Thus, this opens the possibility that PS-
exposing RBC are cleared in the spleen by phagocytosis by one
or more of these PS or PS/ligand receptor pairs. As was already
mentioned above, the loss of phospholipid asymmetry and the
subsequent exposure of PS on the RBC surface in apoptotic cells
may be a general trigger for RBC removal. It also seems that
upon RBC storage the susceptibility to stress-induced PS expo-
sure increases, thereby causing a considerable fraction of the RBC
to be susceptible to removal after transfusion (Bosman et al.,
2011).
Of interest, N-Acetyl-L-Cysteine (NAC) prolong the half-life
of circulating mouse erythrocytes in vivo RBC drawn from mice
that were subsequently treated with NAC exhibited a significantly
higher survival rate after the intravenous injection into the sibling
mice than those RBC without an NAC treatment (Ghashghaeinia
et al., 2012).
CD47; A MOLECULAR SWITCH FOR RBC PHAGOCYTOSIS
The immunoreceptor signal regulatory protein alpha (SIRPα),
expressed by macrophages, is well-known for its ability to inhibit
phagocytosis of CD47 expressing cells (Oldenborg et al., 2000;
Ishikawa-Sekigami et al., 2006). The CD47-SIRPα interaction
(Figure 4) provides a strong negative signal for phagocytosis and
can function as a marker of “self” on RBC. Thus, a low level of
opsonization might suffice to trigger phagocytosis of a foreign
particle that does not express CD47, whereas a “self” particle,
such as an RBC, would not be phagocytosed by macrophages in
the spleen due to the presence of CD47 on the RBC and the result-
ing inhibitory signals generated upon contact with macrophage
SIRPα. Interestingly, mild hemolytic anemia is seen in Rh-null or
protein 4.2-deficient human individuals (Miller et al., 1987; Bruce
et al., 2002), which both have strongly reduced RBCCD47 expres-
sion levels. Thus it is tempting to speculate that the hemolytic
anemia in these individuals may in part be the result of reduced
CD47-SIRPα inhibitory signaling to splenic macrophages, possi-
bly in combination with the altered morphology and rheological
properties of the RBC in these syndromes.
Based on this, it is of interest to determine whether a reduced
expression of CD47 during RBC senescence is also involved in
facilitating the uptake of these cells by macrophages. Some stud-
ies suggest that there is evidence that point in this direction. One
group has found, that a fraction of older murine RBC (>30 days
old) show about 20% reduced CD47 expression as compared to
a fraction of younger RBC (Fossati-Jimack et al., 2002).Also in
another study, RBC storage, which is known to be associated with
accelerated RBC clearance following transfusion, was shown to
result in loss of CD47 (Anniss and Sparrow, 2002), although we
were not able to reproduce these results for RBC stored under
standard Dutch blood bank conditions (Burger and van Bruggen,
unpublished).These observations, in combination with the pre-
vious findings, suggest that clearance of senescent RBC may be
regulated by the net result of total signaling through macrophage
pro-phagocytic and inhibitory receptors.
However, in 2012 our group has shown that CD47 does not
only function as a “don’t eat me” signal, but can also act as an
“eat me” signal (Burger et al., 2012). In particular, a subset of old
RBC present in whole blood was shown to bind and to be phago-
cytosed via CD47-SIRPα interactions. Furthermore, our group
provided evidence that experimental aging of RBC induces a con-
formational change in CD47 that switches the molecule from an
inhibitory into an activating one. Pre-incubation of experimen-
tally aged RBC with human serum prior to the binding assay was
required for this activation. In the same study we also demon-
strated that aged RBC have the capacity to bind the CD47-binding
partner thrombospondin-1 (TSP-1) and that treatment of aged
RBC with a TSP-1 derived particle enabled their phagocytosis by
human red pulp macrophages. Finally, CD47 on RBC that had
been stored for prolonged time was shown to undergo a confor-
mational change and bind TSP-1. These findings reveal a more
complex role for CD47-SIRPα interactions in RBC clearance, with
CD47 acting as a molecular switch controlling phagocytosis. In
addition, we were able to determine that this CD47/SIRPα path-
way leading to phagocytosis of RBC is operational in human red
pulp macrophages.
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RBC COMPLEMENT RECEPTOR 1: MEDIATOR IN
IMMUNE-ADHERENCE CLEARANCE THROUGH
MACROPHAGES
Immune adherence was first described by Nelson (1953) as
the immunological reaction between RBC and complement
opsonized pathogens. Humans and other higher primates are
unique for immune-adherence clearance (IAC) using comple-
ment receptor 1 (CR1) on the RBC membrane, which is a critical
protection in host defense against blood-borne pathogens such as
bacteria. For the vast majority of lower primates, not RBC, but
platelets are responsible for binding and transporting circulating
complement opsonized particles.
CR1 on human RBC binds complement opsonized parti-
cles bearing C3b/C4b in the circulation (Ross and Medof, 1985;
Wilson et al., 1987). The opsonized particles are subsequently
transported to the spleen and liver where they are removed
by residential macrophages, without phagocytosing the RBC.
Another group has shown in an in vitro study that the trans-
fer rate of immune complexes to monocytes is accelerated once
the immune complexes are bound to RBC CR1 compared to
unbound opsonized immune complexes, thereby increasing the
efficiency of immune complex removal (Emlen et al., 1992).
Furthermore, in a mouse transgenic model, where human CR1
is expressed on murine RBC, immune adherence was shown to
enhance the resistance of the host to infection with S. pneumoniae
(Li et al., 2010a).
Recently, interesting work by Melhorn and colleagues on the
interplay between RBC and phagocytes in transfer of opsonized
particles has been published. It was shown that signal transduc-
tion downstream of CR1 after particle binding results in alter-
ations in RBC membrane deformability and in clustering of CR1
on the RBC surface, which enhances binding of the opsonized
particle. But more importantly, proof was provided that CR1 lig-
ation leads to ATP secretion, which has a direct stimulatory effect
on particle uptake by phagocytes (Melhorn et al., 2013). Thus,
the RBC seems to play an active role in the capture of opsonized
particles as well as the subsequent transfer of these particles to
phagocytes.
RBC MACROPHAGE INTERACTIONS: FUTURE DIRECTIONS
Macrophages play a pivotal role in RBC production, mainte-
nance and clearance. Although it is clear that macrophage–
RBC interactions are critical in these processes, the molecular
mechanisms behind many of these interactions are still elu-
sive. The role of macrophages in the formation of erythroblastic
islands is the most extensively studied process in which RBC
macrophage interactions are important. The other two biological
phenomena, maintenance and clearance of RBC are less well-
understood. Especially, the process in which macrophages of the
spleen aid the removal of inclusions in the RBC, are obscure.
In the near future efforts should be made to fully understand
this process as well as RBC clearance. New techniques such as
intravital microscopy might be used to study these processes in
detail, thereby generating knowledge that may aid to prevent
unwanted RBC destruction in diseases such as β-Thalassemia or
hemolytic anemia, or reduce the loss of stored donor RBC after
transfusion.
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